Effector Therapeutics

Key People/Management at Effector Therapeutics

Larry Lasky

Larry Lasky

Director
Simeon George

Simeon George

Director
Steve Worland

Steve Worland

President and Chief Executive Officer, Director
Premal Patel

Premal Patel

Chief Medical Officer
Alana McNulty

Alana McNulty

Chief Business Officer
Denis Patrick

Denis Patrick

Director
Show more

Effector Therapeutics Office Locations

Effector Therapeutics has an office in San Diego
San Diego, CA, US (HQ)
11180 Roselle St
Show all (1)

Effector Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2012

Effector Therapeutics total Funding

$101 m

Effector Therapeutics latest funding size

$16 m

Time since last funding

5 years ago

Effector Therapeutics investors

Effector Therapeutics's latest funding round in February 2016 was reported to be $16 m. In total, Effector Therapeutics has raised $101 m
Show all financial metrics

Effector Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Effector Therapeutics Online and Social Media Presence

Embed Graph

Effector Therapeutics Blogs

eFFECTOR’s Zotatifin (eFT226) Downregulates Key Oncogenic Driver Proteins Including RTKs (HER2, FGFR1 and FGFR2) Providing Single Agent Activity and Key Combination Opportunities

SAN DIEGO, OCTOBER 26, 2020 – eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulation inhibitors (STRIs) for the treatment of cancer, today announced that data presented over the weekend at the EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium (E…

eFFECTOR’s Tomivosertib Demonstrates Positive Phase 2 Results for Subjects with Non-Small Cell Lung Cancer in Combination with Checkpoint Inhibitors

SAN DIEGO, MAY 29, 2020 – eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulation inhibitors (STRIs) for the treatment of cancer, today announced that positive Phase 2 data from its pipeline program tomivosertib (eFT508)

eFFECTOR’s Zotatifin Demonstrates in vitro Anti-SARS-CoV-2 Activity in Independent International Study Reported in Peer-Reviewed Journal Nature

SAN DIEGO, April 30, 2020 – eFFECTOR Therapeutics, Inc., today announced that preliminary results from an independent preclinical study showed that oncology product candidate zotatifin (eFT226) had in vitro antiviral activity against SARS-CoV-2, the virus that causes COVID-19. The results of the res…

eFFECTOR’s Zotatifin (eFT226) Inhibited Tumor Growth and Caused Tumor Regression Across Diverse Receptor Tyrosine Kinase-Driven Tumor Types in Preclinical Models of Disease

SAN DIEGO, April 27, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, announced that data presented today in a virtual session at the AACR Annual Meeting,

eFFECTOR to Present During BIO CEO & Investor Conference

San Diego, February 6, 2020—eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced that Steve Worland, Ph.D., president and chief executive officer of eFFECTOR, will present a company overview during the BIO CE…
Show more

Effector Therapeutics Frequently Asked Questions

  • When was Effector Therapeutics founded?

    Effector Therapeutics was founded in 2012.

  • Who are Effector Therapeutics key executives?

    Effector Therapeutics's key executives are Larry Lasky, Simeon George and Steve Worland.

  • How many employees does Effector Therapeutics have?

    Effector Therapeutics has 22 employees.

  • Who are Effector Therapeutics competitors?

    Competitors of Effector Therapeutics include Scorpion Therapeutics, HiberCell and BioNTech.

  • Where is Effector Therapeutics headquarters?

    Effector Therapeutics headquarters is located at 11180 Roselle St, San Diego.

  • Where are Effector Therapeutics offices?

    Effector Therapeutics has an office in San Diego.

  • How many offices does Effector Therapeutics have?

    Effector Therapeutics has 1 office.